Wound Dressings Market - Global Forecast to 2030
商品番号 : SMB-85926
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年8月 |
| ページ数 | 353 |
| 図表数 | 444 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
本レポートは、創傷被覆材市場を、種類、創傷タイプ、エンドユーザー、および国別に分析しています。また、市場の成長に影響を与える要因(促進要因、抑制要因、機会、課題など)を分析するとともに、市場リーダーの競争環境の詳細も提供しています。さらに、ミクロ市場を個々の成長傾向の観点から分析しています。さらに、5つの主要地域(および各地域に属する国)における市場セグメントの収益予測も提供しています。
本レポートは、既存企業だけでなく新規参入企業や小規模企業も市場の動向を把握し、より大きな市場シェアを獲得することを可能にします。本レポートを購入した企業は、以下に示す戦略のいずれか、または組み合わせて活用することで、市場プレゼンスを強化することができます。
世界の創傷被覆材市場は、予測期間中に6.5%のCAGRで成長し、2025年の116億米ドルから2030年には158億7,000万米ドルに達すると予測されています。
市場の成長を牽引しているのは、主に火傷の発生率上昇、慢性創傷、外科創傷、外傷の罹患率増加、高齢女性における帝王切開率の高さ、そして交通事故の増加です。しかしながら、高度な創傷被覆材の高コストと普及の少なさが、予測期間中の市場成長を阻害すると予想されます。
The global wound dressings market is projected to reach USD 15.87 billion by 2030 from USD 11.60 billion in 2025, at a CAGR of 6.5% during the forecast period.
The market is primarily driven by the rising incidence of burn injuries, increasing prevalence of chronic, surgical, and traumatic wounds, a high rate of cesarean sections among elderly women, and a growing number of road accidents. However, the high cost and limited adoption of advanced wound dressings are anticipated to hinder market growth during the forecast period.
The advanced wound dressings segment accounted for the largest share of the wound dressings market, by type.

Based on type, the wound dressings market is segmented into traditional wound dressings and advanced wound dressings. In 2024, the advanced wound dressings segment captured the largest share of the wound dressings market by type. This can be largely attributed to the growing incidence of chronic wounds such as diabetic foot ulcers, venous leg ulcers, and pressure ulcers, which require specialized and more effective treatment approaches. Additionally, factors such as the rising prevalence of diabetes, increased awareness among patients regarding wound management, advancements in wound care technologies, and the growing burden of hospital-acquired infections (HAIs) are contributing to the strong demand for advanced wound dressings. These products offer faster healing, reduced infection risk, and improved patient outcomes, further driving their adoption.
The surgical and traumatic wounds accounted for the largest market share in the wound dressings market.
Based on wound type, the market has been segmented into surgical and traumatic wounds, diabetic foot ulcers, pressure ulcers, venous leg ulcers, and burns & other wounds. Based on wound type, the surgical and traumatic wounds segment held the largest share of the wound dressings market in 2024. The significant share is primarily due to the rising number of surgical interventions worldwide and the increasing incidence of traumatic injuries resulting from accidents and falls. Furthermore, the growing elderly population, who are more prone to chronic conditions and surgeries, as well as the global rise in road traffic accidents, contribute to the segment’s dominance. This segment is also projected to witness the highest CAGR during the forecast period, owing to continuous improvements in surgical techniques, post-operative care, and the increasing use of wound dressings in hospital and home care settings.

Asia Pacific is the fastest-growing region of the wound dressings market, by region.
The global wound dressings market is categorized into five key regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Among these, the Asia Pacific region is experiencing rapid growth, driven by an aging population and a rising prevalence of lifestyle-related conditions that contribute to chronic wounds. The increasing demand for high-quality healthcare services, along with substantial investments in hospital infrastructure and advanced medical technologies, is fueling the uptake of advanced wound care dressings. Additionally, the growing medical tourism industry in countries such as India, Thailand, and Singapore has led to a rise in surgical procedures, thereby increasing the need for effective post-operative wound care. With a strong focus among healthcare providers on enhancing patient outcomes and shortening recovery periods, the Asia Pacific market is expected to register the highest compound annual growth rate (CAGR) during the forecast period.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1: 40%, Tier 2: 30%, and Tier 3: 30%
- By Designation: C Level: 27%, Director Level: 18%, and Others: 55%
- By Region: North America: 51%, Europe: 21%, Asia Pacific: 18%, Latin America: 6%, and Middle East & Africa: 4%
Note 1: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.
Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.
Note 3: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
The major players operating in the wound dressings market are Solventum (US), Smith+ Nephew (UK), Convatec Group PLC (UK), Coloplast Group (Denmark), Cardinal Health (US), Mölnlycke AB (Sweden), Integra LifeSciences Corporation (US), PAUL HARTMANN AG (Germany), B.Braun SE (Germany), Essity Aktiebolag (Sweden), Advanced Medical Solutions Group plc (UK), Mativ Holdings, Inc. (US), Owens & Minor (US), Lohmann & Rausher GmbH & Co. KG (Germany), Medline Industries, LP (US), DeRoyal Industries, Ine. (US), Winner Medical Co., LTD. (China), Advancis (UK), Hollister Incorporated (US), DermaRite Industries, LLC. (US), Mil Laboratories Pvt. Ltd. (India), Urgo Group (France), Gentell (US), Shield Line (US), and Focus Health Group (US)

Research Coverage
This report studies the wound dressings market based on type, wound type, end user, and country. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends. It forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the strategies mentioned below to strengthen their market presence.
This report provides insights on the following pointers:
Analysis of key drivers (growing geriatric population, increasing cases of traumatic injuries, growing prevalence of chronic diseases rising incidence of burn injuries, rising use of regenerative medicine for wound management, and government initiatives and reimbursement policies), restraints (high cost of advanced wound care products, risks associated with use of advanced wound care products and antimicrobial resistance challenges), opportunities (Growth opportunities in emerging economies, technological advancement in wound care, and home-care optimized solutions), challenges (lack of trained healthcare professionals, Limited awareness in underdeveloped regions, and data security and privacy concerns)
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the wound dressings market
- Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the wound dressings market
- Market Development: Comprehensive information on lucrative emerging regions
- Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the wound dressings market
- Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players
Table of Contents
1 INTRODUCTION 30
1.1 STUDY OBJECTIVES 30
1.2 MARKET DEFINITION 30
1.3 STUDY SCOPE 31
1.3.1 MARKETS COVERED & REGIONAL SCOPE 31
1.3.2 INCLUSIONS & EXCLUSIONS 32
1.3.3 YEARS CONSIDERED 33
1.4 CURRENCY CONSIDERED 33
1.5 STAKEHOLDERS 33
1.6 SUMMARY OF CHANGES 34
2 RESEARCH METHODOLOGY 35
2.1 RESEARCH DATA 35
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 36
2.1.2 PRIMARY DATA 37
2.1.2.1 Primary sources 37
2.1.2.2 Key industry insights 38
2.1.2.3 Key data from primary sources 38
2.1.2.4 Breakdown of primary interviews 39
2.2 MARKET SIZE ESTIMATION 40
2.2.1 BOTTOM-UP APPROACH 40
2.2.1.1 Approach 1: Company revenue estimation approach 40
2.2.1.2 Approach 2: Presentations of companies and primary interviews 41
2.2.1.3 Approach 3: Primary interviews 41
2.2.1.4 Growth forecast 41
2.2.1.5 CAGR projections 42
2.2.2 TOP-DOWN APPROACH 42
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 43
2.4 RESEARCH ASSUMPTIONS 44
2.4.1 STUDY-RELATED ASSUMPTIONS 44
2.4.2 PARAMETRIC ASSUMPTIONS 44
2.5 RESEARCH LIMITATIONS 44
2.6 RISK ASSESSMENT 45
3 EXECUTIVE SUMMARY 46
4 PREMIUM INSIGHTS 50
4.1 WOUND DRESSINGS MARKET OVERVIEW 50
4.2 ASIA PACIFIC: WOUND DRESSINGS MARKET SHARE, BY END USER AND COUNTRY 51
4.3 WOUND DRESSINGS MARKET: GEOGRAPHIC SNAPSHOT 52
4.4 WOUND DRESSINGS MARKET, REGIONAL MIX, 2025 VS. 2030 52
5 MARKET OVERVIEW 53
5.1 INTRODUCTION 53
5.2 MARKET DYNAMICS 53
5.2.1 DRIVERS 54
5.2.1.1 Increasing burden of chronic illnesses and conditions that impair natural wound healing 54
5.2.1.2 Rising cases of burn-related injuries globally 55
5.2.1.3 Increasing number of road accidents and trauma injuries 56
5.2.1.4 Elevated rate of cesarean deliveries in elderly mothers 57
5.2.1.5 Technological advancements in wound dressings 58
5.2.2 RESTRAINTS 59
5.2.2.1 High cost of advanced wound dressings 59
5.2.2.2 Potential risks and complications linked to wound dressings 60
5.2.2.3 Antimicrobial resistance challenges 60
5.2.3 OPPORTUNITIES 61
5.2.3.1 Growth opportunities in emerging economies 61
5.2.3.2 Supportive government initiatives and favorable reimbursement frameworks 61
5.2.4 CHALLENGES 62
5.2.4.1 Lack of trained healthcare professionals 62
5.2.4.2 Gaps in awareness and accessibility across emerging markets 62
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 63
5.4 PRICING ANALYSIS 63
5.4.1 AVERAGE SELLING PRICE TREND, BY PRODUCT, 2023–2025 64
5.4.2 AVERAGE SELLING PRICE TREND OF WOUND DRESSING PRODUCTS FOR KEY WOUND TYPES, BY KEY PLAYER, 2023–2025 64
5.4.3 AVERAGE SELLING PRICE TREND, BY REGION, 2023–2025 65
5.5 VALUE CHAIN ANALYSIS 65
5.6 SUPPLY CHAIN ANALYSIS 67
5.7 ECOSYSTEM ANALYSIS 68
5.8 INVESTMENT & FUNDING SCENARIO 69
5.9 TECHNOLOGY ANALYSIS 70
5.9.1 KEY TECHNOLOGIES 70
5.9.1.1 Bioactive wound dressings 70
5.9.2 COMPLEMENTARY TECHNOLOGIES 71
5.9.2.1 Antimicrobial coating technology 71
5.9.3 ADJACENT TECHNOLOGIES 71
5.9.3.1 Negative-pressure wound therapy 71
5.10 PATENT ANALYSIS 72
5.11 TRADE ANALYSIS 74
5.11.1 IMPORT SCENARIO 74
5.11.2 EXPORT SCENARIO 75
5.12 KEY CONFERENCES & EVENTS, 2025–2026 76
5.13 CASE STUDY ANALYSIS 77
5.13.1 CASE STUDY 1: HYDROCOLL HYDROCOLLOID DRESSINGS ACCELERATE HEALING IN CHRONIC WOUNDS 77
5.13.2 CASE STUDY 2: BIATAIN SILICONE ENHANCES COMFORT AND HEALING IN CHRONIC WOUNDS 78
5.13.3 CASE STUDY 3: MEPILEX UP REDUCES LEAKAGE AND IMPROVES LIFE QUALITY IN VENOUS LEG ULCERS 78
5.14 REGULATORY ANALYSIS 79
5.14.1 REGULATORY LANDSCAPE 79
5.14.1.1 North America 79
5.14.1.1.1 US 79
5.14.1.1.2 Canada 79
5.14.1.2 Europe 79
5.14.1.2.1 Germany 80
5.14.1.2.2 UK 80
5.14.1.2.3 France 80
5.14.1.3 Asia Pacific 80
5.14.1.3.1 China 80
5.14.1.3.2 Japan 81
5.14.1.3.3 India 81
5.14.1.4 Latin America 81
5.14.1.5 Middle East 82
5.14.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 82
5.14.2.1 North America 82
5.14.2.2 Europe 82
5.14.2.3 Asia Pacific 83
5.14.2.4 Latin America 83
5.14.2.5 Rest of the World 84
5.15 PORTER’S FIVE FORCES ANALYSIS 84
5.15.1 BARGAINING POWER OF SUPPLIERS 85
5.15.2 BARGAINING POWER OF BUYERS 85
5.15.3 THREAT OF NEW ENTRANTS 85
5.15.4 THREAT OF SUBSTITUTES 85
5.15.5 INTENSITY OF COMPETITIVE RIVALRY 86
5.16 KEY STAKEHOLDERS & BUYING CRITERIA 86
5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS 86
5.16.2 BUYING CRITERIA 87
5.17 IMPACT OF AI ON WOUND DRESSINGS MARKET 88
5.17.1 INTRODUCTION 88
5.17.2 MARKET POTENTIAL OF AI IN WOUND DRESSINGS MARKET 88
5.17.3 IMPACT OF AI ON WOUND DRESSINGS MARKET: USE CASES 89
5.17.4 KEY COMPANIES IMPLEMENTING AI 90
5.17.5 FUTURE OF AI IN WOUND DRESSINGS MARKET 90
5.18 IMPACT OF US 2025 TARIFFS ON WOUND DRESSINGS MARKET 90
5.18.1 INTRODUCTION 90
5.18.2 KEY TARIFF RATES 91
5.18.3 PRICE IMPACT ANALYSIS 92
5.18.4 IMPACT ON COUNTRY/REGION 92
5.18.4.1 North America 92
5.18.4.2 Europe 92
5.18.4.3 Asia Pacific 92
5.18.5 IMPACT ON END-USE INDUSTRIES 93
5.18.5.1 Hospitals, ASCs, and clinics 93
6 WOUND DRESSINGS MARKET, BY TYPE 94
6.1 INTRODUCTION 95
6.2 ADVANCED WOUND DRESSINGS 95
6.2.1 FOAM DRESSINGS 98
6.2.1.1 Silicone dressings 102
6.2.1.1.1 Ability of silicone dressings to expedite wound closure and reduce risk of maceration to drive market 102
6.2.1.2 Non-silicone dressings 104
6.2.1.2.1 Advantages such as scar removal and wound healing to drive demand for non-silicone dressings 104
6.2.2 HYDROCOLLOID DRESSINGS 106
6.2.2.1 Ability to promote granulation and formation of new tissues in open wounds to boost adoption 106
6.2.3 FILM DRESSINGS 109
6.2.3.1 Non-absorbable nature of film dressings to limit adoption 109
6.2.4 ALGINATE DRESSINGS 112
6.2.4.1 Growing incidence of pressure and diabetic foot ulcers to fuel growth 112
6.2.5 HYDROGEL DRESSINGS 114
6.2.5.1 Ability to provide relief and cooling effect on skin to drive use of hydrogel dressings 114
6.2.6 COLLAGEN DRESSINGS 117
6.2.6.1 Favorable reimbursement scenario for collagen dressings to support market 117
6.2.7 HYDROFIBER DRESSINGS 120
6.2.7.1 Combination of properties of hydrocolloids and alginates to boost adoption of hydrofiber dressings 120
6.2.8 WOUND CONTACT LAYERS 122
6.2.8.1 Ability to protect wound beds from bacterial and fungal growth to drive growth 122
6.2.9 SUPERABSORBENT DRESSINGS 125
6.2.9.1 Use of superabsorbent dressings for fragile skin to promote growth 125
6.2.10 OTHER ADVANCED WOUND DRESSINGS 128
6.3 TRADITIONAL WOUND DRESSINGS 131
6.3.1 GAUZES 134
6.3.1.1 Wide usage of gauzes in surgeries and wound packing to propel market growth 134
6.3.2 TAPES 137
6.3.2.1 Importance of secure fixation, comfort, and reduced trauma to drive demand 137
6.3.3 BANDAGES 140
6.3.3.1 Wide usage of bandages to support market growth 140
6.3.4 ABSORBENT PADS 142
6.3.4.1 Wide usage of absorbent pads in wound dressing and exudate management to drive market 142
6.3.5 OTHER TRADITIONAL WOUND DRESSINGS 145
7 WOUND DRESSINGS MARKET, BY WOUND TYPE 148
7.1 INTRODUCTION 149
7.2 SURGICAL & TRAUMATIC WOUNDS 149
7.2.1 GROWING VOLUME OF SURGICAL PROCEDURES PERFORMED AND INCREASING INCIDENCE OF BURN INJURIES TO SUPPORT MARKET GROWTH 149
7.3 DIABETIC FOOT ULCERS 153
7.3.1 INCREASING PREVALENCE OF DIABETES TO PROPEL MARKET GROWTH 153
7.4 PRESSURE ULCERS 157
7.4.1 GROWING PREVALENCE OF PRESSURE ULCERS TO SUPPORT MARKET GROWTH 157
7.5 VENOUS LEG ULCERS 160
7.5.1 RISING GERIATRIC POPULATION TO SUPPORT GROWTH OF THIS SEGMENT 160
7.6 BURNS & OTHER WOUNDS 163
7.6.1 HIGH INCIDENCE OF BURN INJURIES IN EMERGING COUNTRIES TO PROPEL GROWTH 163
8 WOUND DRESSINGS MARKET, BY END USER 167
8.1 INTRODUCTION 168
8.2 HOSPITALS, ASCS, AND CLINICS 168
8.2.1 RISING NEED FOR BETTER WOUND MANAGEMENT AND GROWING NUMBER OF HOSPITAL READMISSIONS TO SUPPORT MARKET GROWTH 168
8.3 HOME CARE SETTINGS 171
8.3.1 NEED TO CONTROL RISING HEALTHCARE COSTS TO DRIVE MARKET GROWTH 171
8.4 OTHER END USERS 174
9 WOUND DRESSINGS MARKET, BY REGION 178
9.1 INTRODUCTION 179
9.2 NORTH AMERICA 179
9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 180
9.2.2 US 183
9.2.2.1 Rising diabetes prevalence and supportive reimbursement policies to drive market growth 183
9.2.3 CANADA 186
9.2.3.1 Government-backed efforts to support market development 186
9.3 EUROPE 189
9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 189
9.3.2 GERMANY 195
9.3.2.1 Rising diabetes cases and chronic wound burden to boost market growth 195
9.3.3 FRANCE 198
9.3.3.1 Rising chronic wound cases to drive market expansion in France 198
9.3.4 UK 201
9.3.4.1 Increase in R&D activity to propel market growth 201
9.3.5 ITALY 204
9.3.5.1 Growing number of injury-related cases in Italy to propel growth 204
9.3.6 SPAIN 207
9.3.6.1 Rising life expectancy and aging population to boost wound care adoption in Spain 207
9.3.7 RUSSIA 210
9.3.7.1 Government initiatives to raise diabetes awareness to support market expansion in Russia 210
9.3.8 REST OF EUROPE 213
9.4 ASIA PACIFIC 216
9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 217
9.4.2 CHINA 222
9.4.2.1 Increasing incidence of diabetic foot ulcers (DFUs) to encourage growth 222
9.4.3 JAPAN 225
9.4.3.1 Evolving healthcare delivery and infrastructure landscape to fuel market 225
9.4.4 INDIA 228
9.4.4.1 Booming medical tourism to speed up market growth 228
9.4.5 AUSTRALIA 231
9.4.5.1 Growing number of medical manufacturing companies to drive market 231
9.4.6 REST OF ASIA PACIFIC 234
9.5 LATIN AMERICA 237
9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 238
9.5.2 BRAZIL 241
9.5.2.1 Evolving healthcare infrastructure in country to contribute to growth 241
9.5.3 MEXICO 244
9.5.3.1 Expanding hospital infrastructure to aid growth 244
9.5.4 REST OF LATIN AMERICA 247
9.6 MIDDLE EAST & AFRICA 250
9.6.1 GROWING DEMAND FOR HEALTHCARE FACILITIES TO DRIVE MARKET 250
10 COMPETITIVE LANDSCAPE 255
10.1 OVERVIEW 255
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2024 255
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN WOUND DRESSINGS MARKET 256
10.3 REVENUE ANALYSIS, 2022–2024 257
10.4 MARKET SHARE ANALYSIS, 2024 258
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 260
10.5.1 STARS 260
10.5.2 EMERGING LEADERS 260
10.5.3 PERVASIVE PLAYERS 261
10.5.4 PARTICIPANTS 261
10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 262
10.5.5.1 Company footprint 262
10.5.5.2 Region footprint 263
10.5.5.3 Type footprint 264
10.5.5.4 Wound type footprint 265
10.5.5.5 End-user footprint 266
10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 267
10.6.1 PROGRESSIVE COMPANIES 267
10.6.2 RESPONSIVE COMPANIES 267
10.6.3 DYNAMIC COMPANIES 267
10.6.4 STARTING BLOCKS 267
10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 269
10.6.5.1 Detailed list of key startups/SMEs 269
10.6.5.2 Competitive benchmarking of key startups/SMEs 270
10.7 COMPANY VALUATION & FINANCIAL METRICS 271
10.7.1 COMPANY VALUATION 271
10.7.2 FINANCIAL METRICS 271
10.8 BRAND/PRODUCT COMPARISON 272
10.9 COMPETITIVE SCENARIO 272
10.9.1 PRODUCT LAUNCHES & APPROVALS 272
10.9.2 DEALS 273
10.9.3 EXPANSIONS 274
10.9.4 OTHER DEVELOPMENTS 275
11 COMPANY PROFILES 276
11.1 KEY PLAYERS 276
11.1.1 SOLVENTUM 276
11.1.1.1 Business overview 276
11.1.1.2 Products offered 277
11.1.1.3 Recent developments 280
11.1.1.3.1 Product launches & approvals 280
11.1.1.3.2 Other developments 280
11.1.1.4 MnM view 280
11.1.1.4.1 Right to win 280
11.1.1.4.2 Strategic choices 281
11.1.1.4.3 Weaknesses & competitive threats 281
11.1.2 MÖLNLYCKE AB 282
11.1.2.1 Business overview 282
11.1.2.2 Products offered 283
11.1.2.3 Recent developments 285
11.1.2.3.1 Deals 285
11.1.2.3.2 Other developments 286
11.1.2.4 MnM view 286
11.1.2.4.1 Right to win 286
11.1.2.4.2 Strategic choices 286
11.1.2.4.3 Weaknesses & competitive threats 286
11.1.3 CARDINAL HEALTH 287
11.1.3.1 Business overview 287
11.1.3.2 Products offered 288
11.1.3.3 Recent developments 291
11.1.3.3.1 Deals 291
11.1.3.3.2 Expansions 292
11.1.3.4 MnM view 293
11.1.3.4.1 Right to win 293
11.1.3.4.2 Strategic choices 293
11.1.3.4.3 Weaknesses & competitive threats 293
11.1.4 SMITH+NEPHEW 294
11.1.4.1 Business overview 294
11.1.4.2 Products offered 295
11.1.4.3 Recent developments 297
11.1.4.3.1 Deals 297
11.1.4.3.2 Expansions 297
11.1.4.3.3 Other developments 298
11.1.4.4 MnM view 298
11.1.4.4.1 Right to win 298
11.1.4.4.2 Strategic choices 298
11.1.4.4.3 Weaknesses & competitive threats 298
11.1.5 CONVATEC GROUP PLC 299
11.1.5.1 Business overview 299
11.1.5.2 Products offered 300
11.1.5.3 Recent developments 301
11.1.5.3.1 Product launches 301
11.1.5.3.2 Deals 301
11.1.5.4 MnM view 302
11.1.5.4.1 Right to win 302
11.1.5.4.2 Strategic choices 302
11.1.5.4.3 Weaknesses & competitive threats 302
11.1.6 PAUL HARTMANN AG 303
11.1.6.1 Business overview 303
11.1.6.2 Products offered 304
11.1.6.3 Recent developments 307
11.1.6.3.1 Other developments 307
11.1.7 COLOPLAST GROUP 308
11.1.7.1 Business overview 308
11.1.7.2 Products offered 309
11.1.7.3 Recent developments 310
11.1.7.3.1 Product launches 310
11.1.8 OWENS & MINOR 311
11.1.8.1 Business overview 311
11.1.8.2 Products offered 312
11.1.8.3 Recent developments 314
11.1.8.3.1 Deals 314
11.1.8.3.2 Other developments 315
11.1.9 INTEGRA LIFESCIENCES CORPORATION 316
11.1.9.1 Business overview 316
11.1.9.2 Products offered 317
11.1.9.3 Recent developments 318
11.1.9.3.1 Other developments 318
11.1.10 ESSITY AKTIEBOLAG 319
11.1.10.1 Business overview 319
11.1.10.2 Products offered 320
11.1.10.3 Recent developments 323
11.1.10.3.1 Other developments 323
11.1.11 B. BRAUN SE 324
11.1.11.1 Business overview 324
11.1.11.2 Products offered 325
11.1.12 ADVANCED MEDICAL SOLUTIONS GROUP PLC 327
11.1.12.1 Business overview 327
11.1.12.2 Products offered 328
11.1.12.3 Recent developments 329
11.1.12.3.1 Deals 329
11.1.13 MATIV HOLDINGS, INC. 330
11.1.13.1 Business overview 330
11.1.13.2 Products offered 331
11.1.13.3 Recent developments 332
11.1.13.3.1 Deals 332
11.2 OTHER PLAYERS 333
11.2.1 URGO GROUP 333
11.2.2 DEROYAL INDUSTRIES, INC. 334
11.2.3 LOHMANN & RAUSCHER GMBH & CO. KG 335
11.2.4 MEDLINE INDUSTRIES, LP 336
11.2.5 WINNER MEDICAL CO., LTD. 338
11.2.6 ADVANCIS (UK) 339
11.2.7 HOLLISTER INCORPORATED 340
11.2.8 DERMARITE INDUSTRIES, LLC 341
11.2.9 MIL LABORATORIES PVT. LTD. 342
11.2.10 GENTELL 343
11.2.11 SHIELDLINE 344
11.2.12 FOCUS HEALTH GROUP 345
12 APPENDIX 346
12.1 DISCUSSION GUIDE 346
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 349
12.3 CUSTOMIZATION OPTIONS 351
12.4 RELATED REPORTS 351
12.5 AUTHOR DETAILS 352
LIST OF TABLES
TABLE 1 WOUND DRESSINGS MARKET: INCLUSIONS & EXCLUSIONS 32
TABLE 2 WOUND CARE WOUND DRESSINGS MARKET: RISK ASSESSMENT 45
TABLE 3 PEOPLE WITH DIABETES, BY REGION, 2024 VS. 2050 (IN THOUSANDS) 54
TABLE 4 ROAD ACCIDENT DEMOGRAPHICS, 2022 56
TABLE 5 US: CESAREAN DELIVERY RATE, BY STATE (2022) 58
TABLE 6 RISKS ASSOCIATED WITH ADVANCED WOUND DRESSINGS 60
TABLE 7 AVERAGE SELLING PRICING TREND OF WOUND DRESSING PRODUCTS, BY TYPE, 2023–2025 64
TABLE 8 AVERAGE SELLING PRICE TREND OF WOUND DRESSING PRODUCTS FOR KEY WOUND TYPES, BY KEY PLAYER, 2023–2025 64
TABLE 9 AVERAGE SELLING PRICE TREND OF WOUND DRESSING PRODUCTS, BY REGION, 2023–2025 65
TABLE 10 WOUND DRESSINGS MARKET: ROLE OF PLAYERS IN ECOSYSTEM 69
TABLE 11 WOUND DRESSINGS MARKET: INNOVATIONS AND PATENT REGISTRATIONS,
2023–2025 73
TABLE 12 IMPORT DATA FOR HS CODE 300510-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD MILLION) 74
TABLE 13 EXPORT DATA FOR HS CODE 300510-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD MILLION) 75
TABLE 14 WOUND DRESSINGS MARKET: KEY CONFERENCES & EVENTS,
APRIL 2025–DECEMBER 2026 76
TABLE 15 TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS IN JAPAN 81
TABLE 16 NORTH AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 82
TABLE 17 EUROPE: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 82
TABLE 18 ASIA PACIFIC: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 83
TABLE 19 LATIN AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 83
TABLE 20 REST OF THE WORLD: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84
TABLE 21 IMPACT OF PORTER’S FORCES ON WOUND DRESSINGS MARKET 85
TABLE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF WOUND DRESSINGS,
BY END USER (%) 87
TABLE 23 KEY BUYING CRITERIA FOR WOUND DRESSINGS, BY END USER 87
TABLE 24 RECIPROCAL TARIFF RATES ADJUSTED BY US 91
TABLE 25 WOUND DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 95
TABLE 26 ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 96
TABLE 27 ADVANCED WOUND DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION) 96
TABLE 28 NORTH AMERICA: ADVANCED WOUND DRESSINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 97
TABLE 29 EUROPE: ADVANCED WOUND DRESSINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 97
TABLE 30 ASIA PACIFIC: ADVANCED WOUND DRESSINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 98
TABLE 31 LATIN AMERICA: ADVANCED WOUND DRESSINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 98
TABLE 32 KEY FOAM DRESSINGS AVAILABLE IN MARKET 99
TABLE 33 FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 100
TABLE 34 FOAM DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION) 100
TABLE 35 NORTH AMERICA: FOAM DRESSINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 100
TABLE 36 EUROPE: FOAM DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 101
TABLE 37 ASIA PACIFIC: FOAM DRESSINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 101
TABLE 38 LATIN AMERICA: FOAM DRESSINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 102
TABLE 39 SILICONE DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION) 102
TABLE 40 NORTH AMERICA: SILICONE DRESSINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 103
TABLE 41 EUROPE: SILICONE DRESSINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 103
TABLE 42 ASIA PACIFIC: SILICONE DRESSINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 103
TABLE 43 LATIN AMERICA: SILICONE DRESSINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 104
TABLE 44 NON-SILICONE DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION) 104
TABLE 45 NORTH AMERICA: NON-SILICONE DRESSINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 105
TABLE 46 EUROPE: NON-SILICONE DRESSINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 105
TABLE 47 ASIA PACIFIC: NON-SILICONE DRESSINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 106
TABLE 48 LATIN AMERICA: NON-SILICONE DRESSINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 106
TABLE 49 KEY HYDROCOLLOID DRESSINGS AVAILABLE IN MARKET 107
TABLE 50 HYDROCOLLOID DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION) 107
TABLE 51 NORTH AMERICA: HYDROCOLLOID DRESSINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 108
TABLE 52 EUROPE: HYDROCOLLOID DRESSINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 108
TABLE 53 ASIA PACIFIC: HYDROCOLLOID DRESSINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 109
TABLE 54 LATIN AMERICA: HYDROCOLLOID DRESSINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 109
TABLE 55 KEY FILM DRESSINGS AVAILABLE IN MARKET 110
TABLE 56 FILM DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION) 110
TABLE 57 NORTH AMERICA: FILM DRESSINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 111
TABLE 58 EUROPE: FILM DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 111
TABLE 59 ASIA PACIFIC: FILM DRESSINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 111
TABLE 60 LATIN AMERICA: FILM DRESSINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 112
TABLE 61 KEY ALGINATE DRESSINGS AVAILABLE IN MARKET 112
TABLE 62 ALGINATE DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION) 113
TABLE 63 NORTH AMERICA: ALGINATE DRESSINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 113
TABLE 64 EUROPE: ALGINATE DRESSINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 113
TABLE 65 ASIA PACIFIC: ALGINATE DRESSINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 114
TABLE 66 LATIN AMERICA: ALGINATE DRESSINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 114
TABLE 67 KEY HYDROGEL DRESSINGS AVAILABLE IN MARKET 115
TABLE 68 HYDROGEL DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION) 115
TABLE 69 NORTH AMERICA: HYDROGEL DRESSINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 115
TABLE 70 EUROPE: HYDROGEL DRESSINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 116
TABLE 71 ASIA PACIFIC: HYDROGEL DRESSINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 116
TABLE 72 LATIN AMERICA: HYDROGEL DRESSINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 117
TABLE 73 KEY COLLAGEN DRESSINGS AVAILABLE IN MARKET 117
TABLE 74 COLLAGEN DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION) 118
TABLE 75 NORTH AMERICA: COLLAGEN DRESSINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 118
TABLE 76 EUROPE: COLLAGEN DRESSINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 119
TABLE 77 ASIA PACIFIC: COLLAGEN DRESSINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 119
TABLE 78 LATIN AMERICA: COLLAGEN DRESSINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 120
TABLE 79 KEY HYDROFIBER DRESSINGS AVAILABLE IN MARKET 120
TABLE 80 HYDROFIBER DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION) 121
TABLE 81 NORTH AMERICA: HYDROFIBER DRESSINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 121
TABLE 82 EUROPE: HYDROFIBER DRESSINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 121
TABLE 83 ASIA PACIFIC: HYDROFIBER DRESSINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 122
TABLE 84 LATIN AMERICA: HYDROFIBER DRESSINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 122
TABLE 85 KEY WOUND CONTACT LAYERS AVAILABLE IN MARKET 123
TABLE 86 WOUND CONTACT LAYERS MARKET, BY REGION, 2023–2030 (USD MILLION) 123
TABLE 87 NORTH AMERICA: WOUND CONTACT LAYERS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 123
TABLE 88 EUROPE: WOUND CONTACT LAYERS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 124
TABLE 89 ASIA PACIFIC: WOUND CONTACT LAYERS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 124
TABLE 90 LATIN AMERICA: WOUND CONTACT LAYERS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 125
TABLE 91 KEY SUPERABSORBENT DRESSINGS AVAILABLE IN MARKET 125
TABLE 92 SUPERABSORBENT DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION) 126
TABLE 93 NORTH AMERICA: SUPERABSORBENT DRESSINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 126
TABLE 94 EUROPE: SUPERABSORBENT DRESSINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 127
TABLE 95 ASIA PACIFIC: SUPERABSORBENT DRESSINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 127
TABLE 96 LATIN AMERICA: SUPERABSORBENT DRESSINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 128
TABLE 97 OTHER ADVANCED WOUND DRESSINGS AVAILABLE IN MARKET 129
TABLE 98 OTHER ADVANCED WOUND DRESSINGS MARKET, BY REGION,
2023–2030 (USD MILLION) 129
TABLE 99 NORTH AMERICA: OTHER ADVANCED WOUND DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 130
TABLE 100 EUROPE: OTHER ADVANCED WOUND DRESSINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 130
TABLE 101 ASIA PACIFIC: OTHER ADVANCED WOUND DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 131
TABLE 102 LATIN AMERICA: OTHER ADVANCED WOUND DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 131
TABLE 103 TRADITIONAL WOUND DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 132
TABLE 104 TRADITIONAL WOUND DRESSINGS MARKET, BY REGION,
2023–2030 (USD MILLION) 132
TABLE 105 NORTH AMERICA: TRADITIONAL WOUND DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 132
TABLE 106 EUROPE: TRADITIONAL WOUND DRESSINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 133
TABLE 107 ASIA PACIFIC: TRADITIONAL WOUND DRESSINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 133
TABLE 108 LATIN AMERICA: TRADITIONAL WOUND DRESSINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 134
TABLE 109 KEY GAUZES AVAILABLE IN MARKET 134
TABLE 110 GAUZES MARKET, BY REGION, 2023–2030 (USD MILLION) 135
TABLE 111 NORTH AMERICA: GAUZES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 135
TABLE 112 EUROPE: GAUZES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 136
TABLE 113 ASIA PACIFIC: GAUZES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 136
TABLE 114 LATIN AMERICA: GAUZES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 136
TABLE 115 KEY TAPES AVAILABLE IN MARKET 137
TABLE 116 TAPES MARKET, BY REGION, 2023–2030 (USD MILLION) 138
TABLE 117 NORTH AMERICA: TAPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 138
TABLE 118 EUROPE: TAPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 139
TABLE 119 ASIA PACIFIC: TAPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 139
TABLE 120 LATIN AMERICA: TAPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 139
TABLE 121 KEY BANDAGES AVAILABLE IN MARKET 140
TABLE 122 BANDAGES MARKET, BY REGION, 2023–2030 (USD MILLION) 141
TABLE 123 NORTH AMERICA: BANDAGES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 141
TABLE 124 EUROPE: BANDAGES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 141
TABLE 125 ASIA PACIFIC: BANDAGES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 142
TABLE 126 LATIN AMERICA: BANDAGES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 142
TABLE 127 KEY ABSORBENT PADS AVAILABLE IN MARKET 143
TABLE 128 ABSORBENT PADS MARKET, BY REGION, 2023–2030 (USD MILLION) 143
TABLE 129 NORTH AMERICA: ABSORBENT PADS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 143
TABLE 130 EUROPE: ABSORBENT PADS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 144
TABLE 131 ASIA PACIFIC: ABSORBENT PADS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 144
TABLE 132 LATIN AMERICA: ABSORBENT PADS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 144
TABLE 133 OTHER TRADITIONAL WOUND DRESSINGS AVAILABLE IN MARKET 145
TABLE 134 OTHER TRADITIONAL WOUND DRESSINGS MARKET, BY REGION,
2023–2030 (USD MILLION) 145
TABLE 135 NORTH AMERICA: OTHER TRADITIONAL WOUND DRESSINGS MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 146
TABLE 136 EUROPE: OTHER TRADITIONAL WOUND DRESSINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 146
TABLE 137 ASIA PACIFIC: OTHER TRADITIONAL WOUND DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 147
TABLE 138 LATIN AMERICA: OTHER TRADITIONAL WOUND DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 147
TABLE 139 WOUND DRESSINGS MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 149
TABLE 140 WOUND DRESSINGS MARKET FOR SURGICAL & TRAUMATIC WOUNDS, BY REGION, 2023–2030 (USD MILLION) 151
TABLE 141 NORTH AMERICA: WOUND DRESSINGS MARKET FOR SURGICAL & TRAUMATIC WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION) 151
TABLE 142 EUROPE: WOUND DRESSINGS MARKET FOR SURGICAL & TRAUMATIC WOUNDS,
BY COUNTRY, 2023–2030 (USD MILLION) 152
TABLE 143 ASIA PACIFIC: WOUND DRESSINGS MARKET FOR SURGICAL & TRAUMATIC WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION) 152
TABLE 144 LATIN AMERICA: WOUND DRESSINGS MARKET FOR SURGICAL & TRAUMATIC WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION) 153
TABLE 145 TOTAL DIABETES-RELATED HEALTHCARE EXPENDITURE IN 2024 (USD MILLION) 154
TABLE 146 NUMBER OF ADULT PATIENTS WITH DIABETIC FOOT ULCERS, BY COUNTRY,
2023–2030 (IN THOUSANDS) 154
TABLE 147 WOUND DRESSINGS MARKET FOR DIABETIC FOOT ULCERS, BY REGION,
2023–2030 (USD MILLION) 155
TABLE 148 NORTH AMERICA: WOUND DRESSINGS MARKET FOR DIABETIC FOOT ULCERS,
BY COUNTRY, 2023–2030 (USD MILLION) 155
TABLE 149 EUROPE: WOUND DRESSINGS MARKET FOR DIABETIC FOOT ULCERS,
BY COUNTRY, 2023–2030 (USD MILLION) 156
TABLE 150 ASIA PACIFIC: WOUND DRESSINGS MARKET FOR DIABETIC FOOT ULCERS,
BY COUNTRY, 2023–2030 (USD MILLION) 156
TABLE 151 LATIN AMERICA: WOUND DRESSINGS MARKET FOR DIABETIC FOOT ULCERS,
BY COUNTRY, 2023–2030 (USD MILLION) 157
TABLE 152 WOUND DRESSINGS MARKET FOR PRESSURE ULCERS, BY REGION,
2023–2030 (USD MILLION) 158
TABLE 153 NORTH AMERICA: WOUND DRESSINGS MARKET FOR PRESSURE ULCERS,
BY COUNTRY, 2023–2030 (USD MILLION) 158
TABLE 154 EUROPE: WOUND DRESSINGS MARKET FOR PRESSURE ULCERS, BY COUNTRY, 2023–2030 (USD MILLION) 159
TABLE 155 ASIA PACIFIC: WOUND DRESSINGS MARKET FOR PRESSURE ULCERS,
BY COUNTRY, 2023–2030 (USD MILLION) 159
TABLE 156 LATIN AMERICA: WOUND DRESSINGS MARKET FOR PRESSURE ULCERS,
BY COUNTRY, 2023–2030 (USD MILLION) 160
TABLE 157 WOUND DRESSINGS MARKET FOR VENOUS LEG ULCERS, BY REGION,
2023–2030 (USD MILLION) 161
TABLE 158 NORTH AMERICA: WOUND DRESSINGS MARKET FOR VENOUS LEG ULCERS,
BY COUNTRY, 2023–2030 (USD MILLION) 161
TABLE 159 EUROPE: WOUND DRESSINGS MARKET FOR VENOUS LEG ULCERS, BY COUNTRY, 2023–2030 (USD MILLION) 162
TABLE 160 ASIA PACIFIC: WOUND DRESSINGS MARKET FOR VENOUS LEG ULCERS,
BY COUNTRY, 2023–2030 (USD MILLION) 162
TABLE 161 LATIN AMERICA: WOUND DRESSINGS MARKET FOR VENOUS LEG ULCERS,
BY COUNTRY, 2023–2030 (USD MILLION) 163
TABLE 162 WOUND DRESSINGS MARKET FOR BURNS & OTHER WOUNDS, BY REGION,
2023–2030 (USD MILLION) 164
TABLE 163 NORTH AMERICA: WOUND DRESSINGS MARKET FOR BURNS & OTHER WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION) 164
TABLE 164 EUROPE: WOUND DRESSINGS MARKET FOR BURNS & OTHER WOUNDS,
BY COUNTRY, 2023–2030 (USD MILLION) 165
TABLE 165 ASIA PACIFIC: WOUND DRESSINGS MARKET FOR BURNS & OTHER WOUNDS,
BY COUNTRY, 2023–2030 (USD MILLION) 165
TABLE 166 LATIN AMERICA: WOUND DRESSINGS MARKET FOR BURNS & OTHER WOUNDS,
BY COUNTRY, 2023–2030 (USD MILLION) 166
TABLE 167 WOUND DRESSINGS MARKET, BY END USER, 2023–2030 (USD MILLION) 168
TABLE 168 WOUND DRESSINGS MARKET FOR HOSPITALS, ASCS, AND CLINICS MARKET,
BY REGION, 2023–2030 (USD MILLION) 169
TABLE 169 NORTH AMERICA: WOUND DRESSINGS MARKET FOR HOSPITALS, ASCS, AND CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 169
TABLE 170 EUROPE: WOUND DRESSINGS MARKET FOR HOSPITALS, ASCS, AND CLINICS,
BY COUNTRY, 2023–2030 (USD MILLION) 170
TABLE 171 ASIA PACIFIC: WOUND DRESSINGS MARKET FOR HOSPITALS, ASCS, AND CLINICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 170
TABLE 172 LATIN AMERICA: WOUND DRESSINGS MARKET FOR HOSPITALS, ASCS, AND CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 171
TABLE 173 WOUND DRESSINGS MARKET FOR HOME CARE SETTINGS, BY REGION,
2023–2030 (USD MILLION) 172
TABLE 174 NORTH AMERICA: WOUND DRESSINGS MARKET FOR HOME CARE SETTINGS,
BY COUNTRY, 2023–2030 (USD MILLION) 172
TABLE 175 EUROPE: WOUND DRESSINGS AMRKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION) 173
TABLE 176 ASIA PACIFIC: WOUND DRESSINGS MARKET FOR HOME CARE SETTINGS,
BY COUNTRY, 2023–2030 (USD MILLION) 173
TABLE 177 LATIN AMERICA: WOUND DRESSINGS MARKET FOR HOME CARE SETTINGS,
BY COUNTRY, 2023–2030 (USD MILLION) 174
TABLE 178 WOUND DRESSINGS MARKET FOR OTHER END USERS, BY REGION,
2023–2030 (USD MILLION) 175
TABLE 179 NORTH AMERICA: WOUND DRESSINGS MARKET FOR OTHER END USERS,
BY COUNTRY, 2023–2030 (USD MILLION) 175
TABLE 180 EUROPE: WOUND DRESSINGS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 176
TABLE 181 ASIA PACIFIC: WOUND DRESSINGS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 176
TABLE 182 LATIN AMERICA: WOUND DRESSINGS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 177
TABLE 183 WOUND DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION) 179
TABLE 184 NORTH AMERICA: MACROECONOMIC INDICATORS 180
TABLE 185 NORTH AMERICA: WOUND DRESSINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 180
TABLE 186 NORTH AMERICA: WOUND DRESSINGS MARKET, BY TYPE,
2023–2030 (USD MILLION) 181
TABLE 187 NORTH AMERICA: ADVANCED WOUND DRESSINGS MARKET, BY TYPE,
2023–2030 (USD MILLION) 181
TABLE 188 NORTH AMERICA: FOAM DRESSINGS MARKET, BY TYPE,
2023–2030 (USD MILLION) 182
TABLE 189 NORTH AMERICA: TRADITIONAL WOUND DRESSINGS MARKET, BY TYPE,
2023–2030 (USD MILLION) 182
TABLE 190 NORTH AMERICA: WOUND DRESSINGS MARKET, BY WOUND TYPE,
2023–2030 (USD MILLION) 182
TABLE 191 NORTH AMERICA: WOUND DRESSINGS MARKET, BY END USER,
2023–2030 (USD MILLION) 183
TABLE 192 US: WOUND DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 184
TABLE 193 US: ADVANCED WOUND DRESSINGS MARKET, BY TYPE,
2023–2030 (USD MILLION) 184
TABLE 194 US: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 184
TABLE 195 US: TRADITIONAL WOUND DRESSINGS MARKET, BY TYPE,
2023–2030 (USD MILLION) 185
TABLE 196 US: WOUND DRESSINGS MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 185
TABLE 197 US: WOUND DRESSINGS MARKET, BY END USER, 2023–2030 (USD MILLION) 185
TABLE 198 CANADA: ESTIMATED PREVALENCE AND COST OF DIABETES, 2024 VS. 2034 186
TABLE 199 CANADA: WOUND DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 187
TABLE 200 CANADA: ADVANCED WOUND DRESSINGS MARKET, BY TYPE,
2023–2030 (USD MILLION) 187
TABLE 201 CANADA: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 187
TABLE 202 CANADA: TRADITIONAL WOUND DRESSINGS MARKET, BY TYPE,
2023–2030 (USD MILLION) 188
TABLE 203 CANADA: WOUND DRESSINGS MARKET, BY WOUND TYPE,
2023–2030 (USD MILLION) 188
TABLE 204 CANADA: WOUND DRESSINGS MARKET, BY END USER,
2023–2030 (USD MILLION) 188
TABLE 205 EUROPE: MACROECONOMIC INDICATORS 189
TABLE 206 EUROPE: WOUND DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 192
TABLE 207 EUROPE: WOUND DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 192
TABLE 208 EUROPE: ADVANCED WOUND DRESSINGS MARKET, BY TYPE,
2023–2030 (USD MILLION) 193
TABLE 209 EUROPE: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 193
TABLE 210 EUROPE: TRADITIONAL WOUND DRESSINGS MARKET, BY TYPE,
2023–2030 (USD MILLION) 194
TABLE 211 EUROPE: WOUND DRESSINGS MARKET, BY WOUND TYPE,
2023–2030 (USD MILLION) 194
TABLE 212 EUROPE: WOUND DRESSINGS MARKET, BY END USER,
2023–2030 (USD MILLION) 194
TABLE 213 GERMANY: WOUND DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 195
TABLE 214 GERMANY: ADVANCED WOUND DRESSINGS MARKET, BY TYPE,
2023–2030 (USD MILLION) 196
TABLE 215 GERMANY: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 196
TABLE 216 GERMANY: TRADITIONAL WOUND DRESSINGS MARKET, BY TYPE,
2023–2030 (USD MILLION) 197
TABLE 217 GERMANY: WOUND DRESSINGS MARKET, BY WOUND TYPE,
2023–2030 (USD MILLION) 197
TABLE 218 GERMANY: WOUND DRESSINGS MARKET, BY END USER,
2023–2030 (USD MILLION) 197
TABLE 219 FRANCE: WOUND DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 198
TABLE 220 FRANCE: ADVANCED WOUND DRESSINGS MARKET, BY TYPE,
2023–2030 (USD MILLION) 199
TABLE 221 FRANCE: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 199
TABLE 222 FRANCE: TRADITIONAL WOUND DRESSINGS MARKET, BY TYPE,
2023–2030 (USD MILLION) 200
TABLE 223 FRANCE: WOUND DRESSINGS MARKET, BY WOUND TYPE,
2023–2030 (USD MILLION) 200
TABLE 224 FRANCE: WOUND DRESSINGS MARKET, BY END USER,
2023–2030 (USD MILLION) 200
TABLE 225 UK: WOUND DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 201
TABLE 226 UK: ADVANCED WOUND DRESSINGS MARKET, BY TYPE,
2023–2030 (USD MILLION) 202
TABLE 227 UK: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 202
TABLE 228 UK: TRADITIONAL WOUND DRESSINGS MARKET, BY TYPE,
2023–2030 (USD MILLION) 203
TABLE 229 UK: WOUND DRESSINGS MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 203
TABLE 230 UK: WOUND DRESSINGS MARKET, BY END USER, 2023–2030 (USD MILLION) 203
TABLE 231 ITALY: WOUND DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 204
TABLE 232 ITALY: ADVANCED WOUND DRESSINGS MARKET, BY TYPE,
2023–2030 (USD MILLION) 205
TABLE 233 ITALY: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 205
TABLE 234 ITALY: TRADITIONAL WOUND DRESSINGS MARKET, BY TYPE,
2023–2030 (USD MILLION) 206
TABLE 235 ITALY: WOUND DRESSINGS MARKET, BY WOUND TYPE,
2023–2030 (USD MILLION) 206
TABLE 236 ITALY: WOUND DRESSINGS MARKET, BY END USER, 2023–2030 (USD MILLION) 206
TABLE 237 SPAIN: WOUND DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 207
TABLE 238 SPAIN: ADVANCED WOUND DRESSINGS MARKET, BY TYPE,
2023–2030 (USD MILLION) 208
TABLE 239 SPAIN: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 208
TABLE 240 SPAIN: TRADITIONAL WOUND DRESSINGS MARKET, BY TYPE,
2023–2030 (USD MILLION) 209
TABLE 241 SPAIN: WOUND DRESSINGS MARKET, BY WOUND TYPE,
2023–2030 (USD MILLION) 209
TABLE 242 SPAIN: WOUND DRESSINGS MARKET, BY END USER, 2023–2030 (USD MILLION) 209
TABLE 243 RUSSIA: WOUND DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 210
TABLE 244 RUSSIA: ADVANCED WOUND DRESSINGS MARKET, BY TYPE,
2023–2030 (USD MILLION) 211
TABLE 245 RUSSIA: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 211
TABLE 246 RUSSIA: TRADITIONAL WOUND DRESSINGS MARKET, BY TYPE,
2023–2030 (USD MILLION) 212
TABLE 247 RUSSIA: WOUND DRESSINGS MARKET, BY WOUND TYPE,
2023–2030 (USD MILLION) 212
TABLE 248 RUSSIA: WOUND DRESSINGS MARKET, BY END USER, 2023–2030 (USD MILLION) 212
TABLE 249 REST OF EUROPE: WOUND DRESSINGS MARKET, BY TYPE,
2023–2030 (USD MILLION) 213
TABLE 250 REST OF EUROPE: ADVANCED WOUND DRESSINGS MARKET, BY TYPE,
2023–2030 (USD MILLION) 214
TABLE 251 REST OF EUROPE: FOAM DRESSINGS MARKET, BY TYPE,
2023–2030 (USD MILLION) 214
TABLE 252 REST OF EUROPE: TRADITIONAL WOUND DRESSINGS MARKET, BY TYPE,
2023–2030 (USD MILLION) 215
TABLE 253 REST OF EUROPE: WOUND DRESSINGS MARKET, BY WOUND TYPE,
2023–2030 (USD MILLION) 215
TABLE 254 REST OF EUROPE: WOUND DRESSINGS MARKET, BY END USER,
2023–2030 (USD MILLION) 216
TABLE 255 ASIA PACIFIC: KEY MACROECONOMIC INDICATORS 217
TABLE 256 ASIA PACIFIC: WOUND DRESSINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 219
TABLE 257 ASIA PACIFIC: WOUND DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 219
TABLE 258 ASIA PACIFIC: ADVANCED WOUND DRESSINGS MARKET, BY TYPE,
2023–2030 (USD MILLION) 220
TABLE 259 ASIA PACIFIC: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 220
TABLE 260 ASIA PACIFIC: TRADITIONAL WOUND DRESSINGS MARKET, BY TYPE,
2023–2030 (USD MILLION) 221
TABLE 261 ASIA PACIFIC: WOUND DRESSINGS MARKET, BY WOUND TYPE,
2023–2030 (USD MILLION) 221
TABLE 262 ASIA PACIFIC: WOUND DRESSINGS MARKET, BY END USER,
2023–2030 (USD MILLION) 221
TABLE 263 CHINA: WOUND DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 222
TABLE 264 CHINA: ADVANCED WOUND DRESSINGS MARKET, BY TYPE,
2023–2030 (USD MILLION) 223
TABLE 265 CHINA: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 223
TABLE 266 CHINA: TRADITIONAL WOUND DRESSINGS MARKET, BY TYPE,
2023–2030 (USD MILLION) 224
TABLE 267 CHINA: WOUND DRESSINGS MARKET, BY WOUND TYPE,
2023–2030 (USD MILLION) 224
TABLE 268 CHINA: WOUND DRESSINGS MARKET, BY END USER, 2023–2030 (USD MILLION) 224
TABLE 269 JAPAN: WOUND DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 225
TABLE 270 JAPAN: ADVANCED WOUND DRESSINGS MARKET, BY TYPE,
2023–2030 (USD MILLION) 226
TABLE 271 JAPAN: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 226
TABLE 272 JAPAN: TRADITIONAL WOUND DRESSINGS MARKET, BY TYPE,
2023–2030 (USD MILLION) 227
TABLE 273 JAPAN: WOUND DRESSINGS MARKET, BY WOUND TYPE,
2023–2030 (USD MILLION) 227
TABLE 274 JAPAN: WOUND DRESSINGS MARKET, BY END USER, 2023–2030 (USD MILLION) 227
TABLE 275 INDIA: WOUND DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 228
TABLE 276 INDIA: ADVANCED WOUND DRESSINGS MARKET, BY TYPE,
2023–2030 (USD MILLION) 229
TABLE 277 INDIA: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 229
TABLE 278 INDIA: TRADITIONAL WOUND DRESSINGS MARKET, BY TYPE,
2023–2030 (USD MILLION) 230
TABLE 279 INDIA: WOUND DRESSINGS MARKET, BY WOUND TYPE,
2023–2030 (USD MILLION) 230
TABLE 280 INDIA: WOUND DRESSINGS MARKET, BY END USER, 2023–2030 (USD MILLION) 230
TABLE 281 AUSTRALIA: WOUND DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 231
TABLE 282 AUSTRALIA: ADVANCED WOUND DRESSINGS MARKET, BY TYPE,
2023–2030 (USD MILLION) 232
TABLE 283 AUSTRALIA: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 232
TABLE 284 AUSTRALIA: TRADITIONAL WOUND DRESSINGS MARKET, BY TYPE,
2023–2030 (USD MILLION) 233
TABLE 285 AUSTRALIA: WOUND DRESSINGS MARKET, BY WOUND TYPE,
2023–2030 (USD MILLION) 233
TABLE 286 AUSTRALIA: WOUND DRESSINGS MARKET, BY END USER,
2023–2030 (USD MILLION) 233
TABLE 287 REST OF ASIA PACIFIC: WOUND DRESSINGS MARKET, BY TYPE,
2023–2030 (USD MILLION) 234
TABLE 288 REST OF ASIA PACIFIC: ADVANCED WOUND DRESSINGS MARKET, BY TYPE,
2023–2030 (USD MILLION) 235
TABLE 289 REST OF ASIA PACIFIC: FOAM DRESSINGS MARKET, BY TYPE,
2023–2030 (USD MILLION) 235
TABLE 290 REST OF ASIA PACIFIC: TRADITIONAL WOUND DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 236
TABLE 291 REST OF ASIA PACIFIC: WOUND DRESSINGS MARKET, BY WOUND TYPE,
2023–2030 (USD MILLION) 236
TABLE 292 REST OF ASIA PACIFIC: WOUND DRESSINGS MARKET, BY END USER,
2023–2030 (USD MILLION) 237
TABLE 293 LATIN AMERICA: KEY MACROECONOMIC INDICATORS 238
TABLE 294 LATIN AMERICA: WOUND DRESSINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 238
TABLE 295 LATIN AMERICA: WOUND DRESSINGS MARKET, BY TYPE,
2023–2030 (USD MILLION) 238
TABLE 296 LATIN AMERICA: ADVANCED WOUND DRESSINGS MARKET, BY TYPE,
2023–2030 (USD MILLION) 239
TABLE 297 LATIN AMERICA: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 239
TABLE 298 LATIN AMERICA: TRADITIONAL WOUND DRESSINGS MARKET, BY TYPE,
2023–2030 (USD MILLION) 240
TABLE 299 LATIN AMERICA: WOUND DRESSINGS MARKET, BY WOUND TYPE,
2023–2030 (USD MILLION) 240
TABLE 300 LATIN AMERICA: WOUND DRESSINGS MARKET, BY END USER,
2023–2030 (USD MILLION) 241
TABLE 301 BRAZIL: WOUND DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 242
TABLE 302 BRAZIL: ADVANCED WOUND DRESSINGS MARKET, BY TYPE,
2023–2030 (USD MILLION) 242
TABLE 303 BRAZIL: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 242
TABLE 304 BRAZIL: TRADITIONAL WOUND DRESSINGS MARKET, BY TYPE,
2023–2030 (USD MILLION) 243
TABLE 305 BRAZIL: WOUND DRESSINGS MARKET, BY WOUND TYPE,
2023–2030 (USD MILLION) 243
TABLE 306 BRAZIL: WOUND DRESSINGS MARKET, BY END USER, 2023–2030 (USD MILLION) 243
TABLE 307 MEXICO: WOUND DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 244
TABLE 308 MEXICO: ADVANCED WOUND DRESSINGS MARKET, BY TYPE,
2023–2030 (USD MILLION) 245
TABLE 309 MEXICO: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 245
TABLE 310 MEXICO: TRADITIONAL WOUND DRESSINGS MARKET, BY TYPE,
2023–2030 (USD MILLION) 246
TABLE 311 MEXICO: WOUND DRESSINGS MARKET, BY WOUND TYPE,
2023–2030 (USD MILLION) 246
TABLE 312 MEXICO: WOUND DRESSINGS MARKET, BY END USER, 2023–2030 (USD MILLION) 246
TABLE 313 REST OF LATIN AMERICA: WOUND DRESSINGS MARKET, BY TYPE,
2023–2030 (USD MILLION) 247
TABLE 314 REST OF LATIN AMERICA: ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 248
TABLE 315 REST OF LATIN AMERICA: FOAM DRESSINGS MARKET, BY TYPE,
2023–2030 (USD MILLION) 248
TABLE 316 REST OF LATIN AMERICA: TRADITIONAL WOUND DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 249
TABLE 317 REST OF LATIN AMERICA: WOUND DRESSINGS MARKET, BY WOUND TYPE,
2023–2030 (USD MILLION) 249
TABLE 318 REST OF LATIN AMERICA: WOUND DRESSINGS MARKET, BY END USER,
2023–2030 (USD MILLION) 250
TABLE 319 MIDDLE EAST & AFRICA: KEY MACROECONOMIC INDICATORS 251
TABLE 320 MIDDLE EAST & AFRICA: WOUND DRESSINGS MARKET, BY TYPE,
2023–2030 (USD MILLION) 251
TABLE 321 MIDDLE EAST & AFRICA: ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 252
TABLE 322 MIDDLE EAST & AFRICA: FOAM DRESSINGS MARKET, BY TYPE,
2023–2030 (USD MILLION) 252
TABLE 323 MIDDLE EAST & AFRICA: TRADITIONAL WOUND DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 253
TABLE 324 MIDDLE EAST & AFRICA: WOUND DRESSINGS MARKET, BY WOUND TYPE,
2023–2030 (USD MILLION) 253
TABLE 325 MIDDLE EAST & AFRICA: WOUND DRESSINGS MARKET, BY END USER,
2023–2030 (USD MILLION) 254
TABLE 326 WOUND DRESSINGS MARKET: OVERVIEW OF STRATEGIES DEPLOYED
BY KEY MANUFACTURING COMPANIES, JANUARY 2022–JUNE 2025 256
TABLE 327 WOUND DRESSINGS MARKET: DEGREE OF COMPETITION 258
TABLE 328 WOUND DRESSINGS MARKET: REGION FOOTPRINT 263
TABLE 329 WOUND DRESSINGS MARKET: TYPE FOOTPRINT 264
TABLE 330 WOUND DRESSINGS MARKET: WOUND TYPE FOOTPRINT 265
TABLE 331 WOUND DRESSINGS MARKET: END-USER FOOTPRINT 266
TABLE 332 WOUND DRESSINGS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 269
TABLE 333 WOUND DRESSINGS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 270
TABLE 334 WOUND DRESSINGS MARKET: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022–JUNE 2025 273
TABLE 335 WOUND DRESSINGS MARKET: DEALS, JANUARY 2022–JUNE 2025 273
TABLE 336 WOUND DRESSINGS MARKET: EXPANSIONS, JANUARY 2022–JUNE 2025 274
TABLE 337 WOUND DRESSINGS MARKET: OTHER DEVELOPMENTS,
JANUARY 2022–JUNE 2025 275
TABLE 338 SOLVENTUM: COMPANY OVERVIEW 276
TABLE 339 SOLVENTUM: PRODUCTS OFFERED 277
TABLE 340 SOLVENTUM: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JUNE 2025 280
TABLE 341 SOLVENTUM: OTHER DEVELOPMENTS, JANUARY 2022–JUNE 2025 280
TABLE 342 MÖLNLYCKE AB: COMPANY OVERVIEW 282
TABLE 343 MÖLNLYCKE AB: PRODUCTS OFFERED 283
TABLE 344 MÖLNLYCKE AB: DEALS, JANUARY 2022–JUNE 2025 285
TABLE 345 MÖLNLYCKE AB: OTHER DEVELOPMENTS, JANUARY 2022–JUNE 2025 286
TABLE 346 CARDINAL HEALTH: COMPANY OVERVIEW 287
TABLE 347 CARDINAL HEALTH: PRODUCTS OFFERED 288
TABLE 348 CARDINAL HEALTH: DEALS, JANUARY 2022- MAY 2025 291
TABLE 349 CARDINAL HEALTH: EXPANSIONS, JANUARY 2022–JUNE 2025 292
TABLE 350 SMITH+NEPHEW: COMPANY OVERVIEW 294
TABLE 351 SMITH+NEPHEW: PRODUCTS OFFERED 295
TABLE 352 SMITH+NEPHEW: DEALS, JANUARY 2022–JUNE 2025 297
TABLE 353 SMITH+NEPHEW: EXPANSIONS, JANUARY 2022–JUNE 2025 297
TABLE 354 SMITH+NEPHEW: OTHER DEVELOPMENTS, JANUARY 2022–JUNE 2025 298
TABLE 355 CONVATEC GROUP PLC: COMPANY OVERVIEW 299
TABLE 356 CONVATEC GROUP PLC: PRODUCTS OFFERED 300
TABLE 357 CONVATEC GROUP PLC: PRODUCT LAUNCHES, JANUARY 2022–JUNE 2025 301
TABLE 358 CONVATEC GROUP PLC: DEALS, JANUARY 2022–JUNE 2025 301
TABLE 359 PAUL HARTMANN AG: COMPANY OVERVIEW 303
TABLE 360 PAUL HARTMANN AG: PRODUCTS OFFERED 304
TABLE 361 PAUL HARTMANN AG: OTHER DEVELOPMENTS, JANUARY 2022–JUNE 2025 307
TABLE 362 COLOPLAST GROUP: COMPANY OVERVIEW 308
TABLE 363 COLOPLAST GROUP: PRODUCTS OFFERED 309
TABLE 364 COLOPLAST GROUP: PRODUCT LAUNCHES, JANUARY 2022–JUNE 2025 310
TABLE 365 OWENS & MINOR: COMPANY OVERVIEW 311
TABLE 366 OWENS & MINOR: PRODUCTS OFFERED 312
TABLE 367 OWENS & MINOR: DEALS, JANUARY 2022–JANUARY 2025 314
TABLE 368 OWENS & MINOR: OTHER DEVELOPMENTS, JANUARY 2022–JUNE 2025 315
TABLE 369 INTEGRA LIFESCIENCES CORPORATION: COMPANY OVERVIEW 316
TABLE 370 INTEGRA LIFESCIENCES CORPORATION: PRODUCTS OFFERED 317
TABLE 371 INTEGRA LIFESCIENCES CORPORATION: OTHER DEVELOPMENTS,
JANUARY 2022–JUNE 2025 318
TABLE 372 ESSITY AKTIEBOLAG: COMPANY OVERVIEW 319
TABLE 373 ESSITY AKTIEBOLAG: PRODUCTS OFFERED 320
TABLE 374 ESSITY AKTIEBOLAG: OTHER DEVELOPEMENTS, JANUARY 2022–JUNE 2025 323
TABLE 375 B. BRAUN SE: COMPANY OVERVIEW 324
TABLE 376 B. BRAUN SE: PRODUCTS OFFERED 325
TABLE 377 ADVANCED MEDICAL SOLUTIONS GROUP PLC: COMPANY OVERVIEW 327
TABLE 378 ADVANCED MEDICAL SOLUTIONS GROUP PLC: PRODUCTS OFFERED 328
TABLE 379 ADVANCED MEDICAL SOLUTIONS GROUP PLC: DEALS, JANUARY 2022–JUNE 2025 329
TABLE 380 MATIV HOLDINGS, INC.: COMPANY OVERVIEW 330
TABLE 381 MATIV HOLDINGS, INC.: PRODUCTS OFFERED 331
TABLE 382 MATIV HOLDINGS, INC.: DEALS, JANUARY 2022–JUNE 2025 332
TABLE 383 URGO GROUP: COMPANY OVERVIEW 333
TABLE 384 DEROYAL INDUSTRIES, INC.: COMPANY OVERVIEW 334
TABLE 385 LOHMANN & RAUSCHER GMBH & CO. KG: COMPANY OVERVIEW 335
TABLE 386 MEDLINE INDUSTRIES, LP: COMPANY OVERVIEW 336
TABLE 387 WINNER MEDICAL CO., LTD.: COMPANY OVERVIEW 338
TABLE 388 ADVANCIS (UK): COMPANY OVERVIEW 339
TABLE 389 HOLLISTER INCORPORATED: COMPANY OVERVIEW 340
TABLE 390 DERMARITE INDUSTRIES, LLC: COMPANY OVERVIEW 341
TABLE 391 MIL LABORATORIES PVT. LTD.: COMPANY OVERVIEW 342
TABLE 392 GENTELL: COMPANY OVERVIEW 343
TABLE 393 SHIELDLINE: COMPANY OVERVIEW 344
TABLE 394 FOCUS HEALTH GROUP: COMPANY OVERVIEW 345
LIST OF FIGURES
FIGURE 1 WOUND DRESSINGS MARKET SEGMENTATION & REGIONAL SCOPE 31
FIGURE 2 WOUND DRESSINGS MARKET: RESEARCH DESIGN 35
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 39
FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 40
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 42
FIGURE 6 WOUND DRESSINGS MARKET: TOP-DOWN APPROACH 42
FIGURE 7 DATA TRIANGULATION METHODOLOGY 43
FIGURE 8 WOUND DRESSINGS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 46
FIGURE 9 WOUND DRESSINGS MARKET, BY WOUND TYPE, 2025 VS. 2030 (USD MILLION) 47
FIGURE 10 WOUND DRESSINGS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 47
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF WOUND DRESSINGS MARKET 48
FIGURE 12 INCREASING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET GROWTH 50
FIGURE 13 HOSPITALS, ASCS, AND CLINICS ACCOUNTED FOR LARGEST SHARE IN 2024 51
FIGURE 14 JAPAN TO RECORD HIGHEST GROWTH RATE FROM 2025 TO 2030 52
FIGURE 15 ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 52
FIGURE 16 WOUND DRESSINGS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 53
FIGURE 17 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 63
FIGURE 18 WOUND DRESSINGS MARKET: VALUE CHAIN ANALYSIS 66
FIGURE 19 WOUND DRESSINGS MARKET: SUPPLY CHAIN ANALYSIS 67
FIGURE 20 WOUND DRESSINGS MARKET: ECOSYSTEM ANALYSIS 68
FIGURE 21 WOUND DRESSINGS MARKET: INVESTMENT & FUNDING SCENARIO,
2020–2025 (USD MILLION) 70
FIGURE 22 WOUND DRESSINGS MARKET: PATENT ANALYSIS,
JANUARY 2015–DECEMBER 2024 72
FIGURE 23 WOUND DRESSINGS MARKET: PORTER’S FIVE FORCES ANALYSIS 84
FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF WOUND DRESSINGS,
BY END USER 86
FIGURE 25 KEY BUYING CRITERIA FOR WOUND DRESSINGS, BY END USER 87
FIGURE 26 IMPACT OF AI ON WOUND DRESSINGS MARKET: USE CASES 89
FIGURE 27 EUROPE: WOUND DRESSINGS MARKET SNAPSHOT 191
FIGURE 28 ASIA PACIFIC: WOUND DRESSINGS MARKET SNAPSHOT 218
FIGURE 29 WOUND DRESSINGS MARKET: REVENUE ANALYSIS OF KEY PLAYERS,
2022–2024 (USD MILLION) 257
FIGURE 30 MARKET SHARE ANALYSIS OF KEY PLAYERS IN WOUND DRESSINGS
MARKET, 2024 258
FIGURE 31 RANKING OF KEY PLAYERS IN WOUND DRESSINGS MARKET, 2024 260
FIGURE 32 WOUND DRESSINGS MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2024 261
FIGURE 33 WOUND DRESSINGS MARKET: COMPANY FOOTPRINT 262
FIGURE 34 WOUND DRESSINGS MARKET: COMPANY EVALUATION MATRIX
(STARTUPS/SMES), 2024 268
FIGURE 35 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA
OF KEY VENDORS 271
FIGURE 36 EV/EBITDA OF KEY VENDORS 271
FIGURE 37 WOUND DRESSINGS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 272
FIGURE 38 SOLVENTUM: COMPANY SNAPSHOT (2024) 277
FIGURE 39 MÖLNLYCKE AB: COMPANY SNAPSHOT (2024) 283
FIGURE 40 CARDINAL HEALTH: COMPANY SNAPSHOT (2024) 288
FIGURE 41 SMITH+NEPHEW: COMPANY SNAPSHOT (2024) 295
FIGURE 42 CONVATEC GROUP PLC: COMPANY SNAPSHOT (2024) 300
FIGURE 43 PAUL HARTMANN AG: COMPANY SNAPSHOT (2024) 304
FIGURE 44 COLOPLAST GROUP: COMPANY SNAPSHOT (2024) 309
FIGURE 45 OWENS & MINOR: COMPANY SNAPSHOT (2024) 312
FIGURE 46 INTEGRA LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2024) 317
FIGURE 47 ESSITY AKTIEBOLAG: COMPANY SNAPSHOT (2024) 320
FIGURE 48 B. BRAUN SE: COMPANY SNAPSHOT (2024) 325
FIGURE 49 ADVANCED MEDICAL SOLUTIONS GROUP PLC: COMPANY SNAPSHOT (2024) 328
FIGURE 50 MATIV HOLDINGS, INC.: COMPANY SNAPSHOT (2024) 331
MarketsandMarkets(マーケッツアンドマーケッツ)は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間~12時間以内(営業日基準)にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨(定価)を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料(ハンドリングチャージ)無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内(関連会社除く)5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100%持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内(営業日基準)
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11